Kingdon Capital Management’s Otonomy, Inc. OTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-312,453
Closed -$4.21M 143
2017
Q2
$5.89M Sell
312,453
-461,240
-60% -$6.43M 0.4% 66
2017
Q1
$9.48M Buy
773,693
+168,833
+28% +$2.46M 0.52% 55
2016
Q4
$9.62M Buy
604,860
+109,786
+22% +$1.84M 0.47% 65
2016
Q3
$9.01M Buy
495,074
+127,487
+35% +$2.08M 0.41% 58
2016
Q2
$5.84M Buy
367,587
+190,000
+107% +$2.83M 0.32% 73
2016
Q1
$2.65M Buy
177,587
+60,000
+51% +$943K 0.15% 88
2015
Q4
$3.26M Buy
117,587
+7,587
+7% +$189K 0.16% 92
2015
Q3
$1.96M Buy
+110,000
New +$2.6M 0.09% 105

Other funds holding OTIC

Kingdon Capital Management's OTIC Position: Q3 2017 in Review

Kingdon Capital Management sold out of Otonomy, Inc. (OTIC) in Q3 2017, closing a stake of 312,453 shares — an estimated $4.21M sold.

Kingdon Capital Management first reported a position in OTIC in Q3 2015 and held it in 8 quarters. The position peaked at $9.62M in Q4 2016. 84 funds tracked by Wall St. Rank hold OTIC as of Q3 2017.

  • Kingdon Capital Management reported no remaining Otonomy, Inc. position as of Q3 2017 after selling out during the quarter.
  • Kingdon Capital Management sold 312,453 Otonomy, Inc. shares in Q3 2017, an estimated $4.21M.
  • Kingdon Capital Management first reported a position in Otonomy, Inc. in Q3 2015 and held it in 8 quarters.
  • Kingdon Capital Management's Otonomy, Inc. position peaked at $9.62M in Q4 2016.
  • 84 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q3 2017.

Based on Kingdon Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.